Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
NORTHWEST BIO (NQ: NWBO)
3.710 USD  +0.070 (+1.92%)
Official Closing Price  /  Updated: 8:10 PM EDT, May 17, 2013  /  Add to My Watchlist      
View: Quote News Research
All news about NORTHWEST BIO
 
Northwest Bio (NWBO) Initiates P3 DCVax®-L Brain Cancer Trial
May 16, 2013
King’s College Hospital, UK Is 1st Site of 30 EU Sites to join 46 active sites in US   NWBO P3 clinical trial with DCVax^®-L for brain cancer has been initiated at King’s College Hospital in the UK.... Read More
category Henry McCusker
from Bio-Wire.Com
NW Bio Initiates Phase III DCVax®-L Brain Cancer Trial In Europe: King's College Hospital In The UK Is First Site To Open
May 16, 2013
Up To 30 European Sites To Join 46 Active Sites In The US Read More
from PR Newswire
Interviews Of NW Bio's CEO, On The Floor Of The New York Stock Exchange, Now Available Online
May 03, 2013
from PR Newswire
Mentor Capital Cancer Immunotherapy Index Gains 28% During First Quarter of 2013
May 02, 2013
from Business Wire News Releases
RedChip Emerging Growth Showcase Takes Place May 1
April 23, 2013
Showcase Will Feature Executive Presentations and Interviews From More Than 25 Emerging Growth Companies Read More
from GlobeNewswire News Releases
Indigestion waxes…enthusiasm wanes
April 18, 2013
The 6 W’s: Who, what, where, when, why and what of it RegMed stocks reached for the bromo as markets continue to sour stomachs.  Investors are on the edge, looking for any reason to take money off the... Read More
category Henry McCusker
from Bio-Wire.Com
Northwest Bio (NWBO) Registered Direct Offering – SELL on financing news
April 18, 2013
$10 M for the till Northwest Biotherapeutics (NWBO) has entered into an agreement with one healthcare-dedicated institutional investor for a registered direct placement of $10 M of common stock at the... Read More
category Henry McCusker
from Bio-Wire.Com
NW Bio Announces That Another Brain Cancer Patient From Phase I/II DCVax®-L Trials Has Surpassed Ten-Year Cancer-Free Survival
April 18, 2013
Unprecedented Results Compared With Current Standard of Care Read More
from PR Newswire
NW Bio Announces $10 Million Registered Direct Offering
April 18, 2013
from PR Newswire
NW Biotherapeutics (NWBO) Announces Adoption of its Phase III Trial as National Priority Trial in UK
April 17, 2013
from PRBuzz Press Release Distribution
NASDAQ Gainers Watch List: ECOtality, Inc. (NASDAQ:ECTY), Anaren, Inc. (NASDAQ:ANEN), and Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) Added to Growing Stock Report's NASDAQ Gainers Watch List.
April 16, 2013
New York, NY -- (SBWIRE) -- 04/16/2013 -- Growing Stock Report expands its NASDAQ Gainers Weekly Watch List adding ECOtality, Inc. (NASDAQ:ECTY), Anaren, Inc. (NASDAQ:ANEN), and Northwest... Read More
from SBWire - Latest Press Releases
StreetInsider.com Pre-Open Movers 4/16: (ANEN) (HK) (KO) Higher; (CLI) (LDK) (SRPT) Lower (more...)
April 16, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8255584 for the full story. Read More
from StreetInsider.com News Articles
NW Bio's Phase III Trial With DCVax®-L For Brain Cancer "Adopted" As A National Priority Trial In UK
April 16, 2013
Trial Sites Will Receive Support from UK Health System Read More
from PR Newswire
NW Bio 2012 Annual Report Shows Strong Progress And Enhancement Of Leadership Position
April 08, 2013
from PR Newswire
Zacks Analyst Grant Zeng: 6 Biotechs with Staggering Potential
April 04, 2013
Zacks Analyst Grant Zeng: 6 Biotechs with Staggering Potential Source: George S. Mack of The Life Sciences Report (4/4/13) http://www.thelifesciencesreport.com/pub/na/15125 When it comes to picking... Read More
category PBIO , NEO , TKMR , and 4 more.
from Bio-Wire.Com
NW Bio To Review Its Leadership Position In Immune Therapy At The 25th Annual Roth Conference
March 19, 2013
CEO Will Discuss Key Strengths and Progress, Announce New Developments Read More
from PR Newswire
Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) and ValueClick, Inc. (NASDAQ:VCLK) Added to Growing Stock Report's NASDAQ Gainers Watch List.
March 18, 2013
New York, NY -- (SBWIRE) -- 03/18/2013 -- Growing Stock Report expands its NASDAQ Gainers Weekly Watch List adding Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) and ValueClick, Inc. (NASDAQ:VCLK). Read More
from SBWire - Latest Press Releases
NW Bio Receives U.S. Patent On Broad Processes For Producing More Potent Dendritic Cells
March 18, 2013
Next Generation Technology Already In DCVax®-Direct; Will Be Applicable To All DCVax® Products Read More
from PR Newswire
Mentor Capital Cancer Immunotherapy Index Gains 32% YTD and Adds Second Generation Firms for 2013
March 15, 2013
from Business Wire News Releases
NANO Stocks to Track: MakeMusic, BioFuel Energy Corp, RF Industries, Northwest Biotherapeutics
March 15, 2013
Lakeway, TX -- (SBWIRE) -- 03/15/2013 -- Bestdamnpennystocks, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the... Read More
from SBWire - Latest Press Releases
NW Bio Establishes Cross-Border Manufacturing And Distribution For DCVax® In Europe
March 12, 2013
Approvals Expanding the Scope of German Manufacturing Are Key Steps Read More
from PR Newswire
Micro Cap Stocks in Focus: Northwest Biotherapeutics, FalconStor Software, Homeowners Choice Inc, Golden Minerals Co
March 08, 2013
Lakeway, TX -- (SBWIRE) -- 03/08/2013 -- Bestdamnpennystocks, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the... Read More
from SBWire - Latest Press Releases
Hot Stocks: NQ Mobile, SolarCity, Northwest Biotherapeutics, Ciena
March 07, 2013
Lakeway, NY -- (SBWIRE) -- 03/07/2013 -- ThePennyStockProfiler.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on... Read More
from SBWire - Latest Press Releases
NW Bio Provides Guidance On Phase III Trial Enrollment Timing: Completion Expected To Be Faster Or More Efficient Than Relevant Comparison Trials
March 07, 2013
from PR Newswire
How Cancer Beats the Immune System
March 06, 2013
from ACCESSWIRE
Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) and Smith & Wesson Holding Corporation (NASDAQ:SWHC) Added to Growing Stock Report's NASDAQ Watch List.
March 05, 2013
New York, NY -- (SBWIRE) -- 03/05/2013 -- Growing Stock Report expands its NASDAQ Watch List adding Northwest Biotherapeutics, Inc. (NASDAQ:NWBO) and Smith & Wesson Holding Corporation (NASDAQ:SWHC) Read More
from SBWire - Latest Press Releases
DCVax®-Direct Phase I/II Trial For All Inoperable Solid Tumors Is Expected To Produce Ongoing Results In 2013
March 05, 2013
Endpoint of Tumor Regression Could Be Seen Within Months Read More
from PR Newswire
Top Biotech. Stocks: Cadence Pharmaceuticals, Codexis, Northwest Biotherapeutics, Vanda Pharmaceuticals Inc
February 27, 2013
Lakeway, TX -- (SBWIRE) -- 02/27/2013 -- Bestdamnpennystocks, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the... Read More
from SBWire - Latest Press Releases
RedChip TV Announces Guest Lineup for This Week's "Money Report" on Fox Business News
February 20, 2013
February 23, 2013 Show to Feature Interviews With Three Emerging Growth Companies Read More
from GlobeNewswire News Releases
Mentor Capital Cancer Immunotherapy Index Posts 11% Annual Loss in 2012 and Adds Companies for 2013
February 19, 2013
from Business Wire News Releases
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here